Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.321
-0.039 (-2.88%)
Sep 15, 2025, 2:35 PM EDT - Market open
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $42.64 million as of September 15, 2025. Its market cap has decreased by -72.62% in one year.
Market Cap
42.64M
Enterprise Value
43.24M
1-Year Change
-72.62%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $42.64M, a decrease of -79.43%. That is a compound annual growth rate of -62.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 43.90M | -64.19% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |